January 5, 2024 Comments Off on New patent for Boehringer Ingelheim drug SYNJARDY XR Posted in: Patent Added Annual Drug Patent Expirations for SYNJARDY+XR Synjardy Xr is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are seven…
The post New patent for Boehringer Ingelheim drug SYNJARDY XR appeared…
January 5, 2024 Comments Off on New patent for Vanda Pharms drug HETLIOZ LQ Posted in: Patent Added Annual Drug Patent Expirations for HETLIOZ+LQ Hetlioz Lq is a drug marketed by Vanda Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Vanda Pharms drug HETLIOZ LQ appeared first on DrugPatentW…